MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Attention-deficit hyperactivity disorder, predominantly hyperactive type (F90.1)

HealthDay 25 June at 03.04 PM

ADHD Meds May Help Control Opioid Use Disorder in Pregnancy

Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental Health.Kevin Y. Xu, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benef

HealthDay 30 January at 11.19 PM

Mislabeled Bottles Trigger Recall of the ADHD Drug Zenzedi

One lot of Zenzedi (dextroamphetamine sulfate) 30-mg tablets is being recalled after a pharmacist found antihistamine tablets (carbinoxamine) in a bottle labeled as Zenzedi, according to a recall notice issued by Azurity Pharmaceuticals Inc.The recall comes amid an <a href="https://www.healthday.com/healthpro-news/child-health/amid-shortages-fe

HealthDay 22 January at 04.50 PM

Sleep Disorders Differ for Autism, ADHD Versus Typical Development

For most types of sleep disorders, there are significant differences for children with autism spectrum disorder (ASD) and those with attention-deficit/hyperactivity disorder (ADHD) compared with typically developing (TD) children, according to a study published online Dec. 29 in Autism Research.Carmen Berenguer, Ph.D., from the Universi

HealthDay 17 January at 11.52 PM

New Rx for Schedule-II Stimulants for ADHD Increased During Pandemic

Incident use of common behavioral health medications remained relatively stable during the COVID-19 pandemic, with the exception of those for attention-deficit/hyperactivity disorder (ADHD), according to a study published online Jan. 10 in&nbsp;JAMA Psychiatry.Grace Chai, Pharm.D., M.P.H., from the U.S. Food and Drug Administration i

HealthDay 30 November at 09.59 PM

Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD

The presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online Nov. 30 in&nbsp;JAMA Network Open.Soo Min Jeon, Pharm.D., Ph.D., from Jeju National University in South Korea, and

HealthDay 29 November at 10.47 PM

Before ADHD Diagnosis, Youth Twice as Likely to Have Used Health Care Services

Two years before attention-deficit/hyperactivity disorder (ADHD) diagnosis, youth with ADHD are twice as likely to use health care services as youth without the condition, according to a study published online Oct. 30 in the&nbsp;Archives of Disease in Childhood.Vibhore Prasad, Ph.D., from King's College London, and colleagues used p

HealthDay 27 November at 05.03 PM

Long-Term Exposure to ADHD Meds Linked to Increased Risk for CVD

Long-term exposure to attention-deficit/hyperactivity disorder (ADHD) medications is associated with an increased risk for cardiovascular disease (CVD), especially hypertension, according to a study published online Nov. 22 in JAMA Psychiatry.Le Zhang, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the assoc